PT  - JOURNAL ARTICLE
ED  - ,
TI  - Managing subclinical hypothyroidism
AID  - 10.1136/dtb.1998.3611
DP  - 1998 Jan 01
TA  - Drug and Therapeutics Bulletin
PG  - 1--3
VI  - 36
IP  - 1
4099  - http://dtb.bmj.com/content/36/1/1.short
4100  - http://dtb.bmj.com/content/36/1/1.full
SO  - Drug Ther Bull1998 Jan 01; 36
AB  - Relevant BNF section: 6.2.1In a patient with overt primary hypothyroidism, management is usually straightforward: treatment with thyroxine should be offered to anyone with characteristic clinical features, a raised serum thyroid stimulating hormone (TSH) concentration and a low serum thyroxine (T4) concentration. More difficult is the management of a patient with subclinical hypothyroidism, in whom serum TSH is raised but T4 level is normal, and who is either asymptomatic or has only non-specific symptoms. Left untreated, some of these patients will eventually develop overt hypothyroidism. Here we discuss the use of thyroxine in patients with subclinical hypothyroidism.